N.sup.2 -arylsulfonyl-L-argininamides and the pharmaceutically a

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

26029356, 2603305, 544 37, 2602936, 26029361, 544356, 2603403, 424319, 544237, 424321, 424309, 544104, 424316, 560 10, 544 58, 560 13, 26029357, 544144, 26034673, 2603472, 544347, 544159, 544354, 544285, 548325, 548327, 260287K, 2603322A, 260287R, 260279R, 2601125R, 26029362, 26032611R, 26032612R, 26029358, 2605011, 260544SJ, 260287DI, 260239BF, 26050111, 26050114, 26050118, 2605012, 260315, 260519, 260556AR, 260544B, A61K 3700, C07C10352

Patent

active

040937127

ABSTRACT:
N.sup.2 -arylsulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof have been found to be effective as pharmaceutical agents for the inhibition and suppression of thrombosis in mammals.

REFERENCES:
patent: 4018913 (1977-04-01), Okamoto et al.
patent: 4018915 (1977-04-01), Okamoto et al.
patent: 4041156 (1977-08-01), Okamoto et al.
patent: 4046876 (1977-09-01), Okamoto et al.
patent: 4055636 (1977-10-01), Okamoto et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

N.sup.2 -arylsulfonyl-L-argininamides and the pharmaceutically a does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with N.sup.2 -arylsulfonyl-L-argininamides and the pharmaceutically a, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N.sup.2 -arylsulfonyl-L-argininamides and the pharmaceutically a will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1493291

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.